Science Applications International Corp (SAIC) · Aug 31, 2026 · Earnings

SAIC beats Q2 estimates and raises FY27 guide, but bookings lag

Beat — Adjusted EPS $3.01 vs ~$2.31 consensus; revenue $1.88B vs ~$1.76B

SAIC delivered a sizable Q2 earnings and revenue beat while lifting FY27 targets. Weak book-to-bill and lower backlog temper the read.

The quarter beat a modest market bar by a wide margin. Published pre-release estimates put adjusted EPS at about $2.31 and revenue near $1.76 billion; SAIC delivered $3.01 and $1.88 billion, respectively—roughly 30% above the EPS estimate and 7% above the revenue estimate.

MetricQ2 FY2027 reportedComparison
Revenue$1.880B~$1.764B consensus; $1.769B prior year
Adjusted diluted EPS$3.01~$2.31 consensus; $3.63 prior year
Adjusted EBITDA$193M$185M prior year
Adjusted EBITDA margin10.3%10.5% prior year
FY2027 revenue guidance$7.2B–$7.3BPrior: $7.0B–$7.2B
FY2027 adjusted EBITDA guidance$750M–$755MPrior: $720M–$730M
FY2027 adjusted diluted EPS guidance$10.65–$10.75Prior: $9.90–$10.10
Q2 book-to-bill0.6xTrailing twelve months: 0.8x
Total backlog$22.136B$22.622B at January 30, 2026

Management converted the strong first-half performance into a meaningful outlook upgrade. Revenue, adjusted EBITDA, margin, and adjusted EPS ranges all moved higher, while free-cash-flow guidance stayed above $600 million. The company explicitly said, “We are raising our guidance to reflect our strong year-to-date performance.” (Fiscal 2027 Guidance)

The underlying operating picture improved, but not as cleanly as the adjusted EPS beat suggests. Revenue rose 6% year over year, with approximately 5.3% organic growth, and adjusted EBITDA increased 4%; however, adjusted EBITDA margin slipped 20 basis points to 10.3%. The filing attributes the margin pressure to higher selling, general and administrative costs. “Adjusting for the impact of acquisitions, revenues grew by approximately 5.3%.” 〔0〕 (Results discussion)

Bookings are the material blemish. Q2 net bookings of approximately $1.2 billion produced only a 0.6x book-to-bill ratio, while trailing twelve-month book-to-bill was 0.8x. Total backlog also declined about 2% from January, although funded backlog increased to $3.8 billion from $3.6 billion. The filing says, “Net bookings for the quarter were approximately $1.2 billion which reflects a book-to-bill ratio of 0.6 and a trailing twelve months book-to-bill ratio of 0.8.” (Bookings and backlog)

Net: a clear earnings beat and genuine guidance raise outweigh softer order flow. Cash generation was mixed—operating cash flow rose to $146 million, but free cash flow fell to $131 million from $150 million—while reported net income and adjusted EPS declined year over year against unusually favorable prior-year comparisons. The result is still decisively better than the standing quarterly expectation, but the low book-to-bill ratio leaves execution of the higher full-year targets dependent on converting existing backlog and recent awards.

Original filing on SEC EDGAR

More Science Applications International Corp news

SAIC beats Q2 estimates and raises FY27 guide, but bookings lag | SAIC Stock News
AllSight

Breaking down Wall Street's
information edge.

A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.

—
8-K events this week
—
filings analyzed in total
live · updated 30s ago
Live events · whole market · · --:--:-- ET
AllSight read
Straight from the 8-K
Verbatim from the filing AllSight decoded — highlighted above. Open on SEC EDGAR ↗
Limited-time offerFree 14-day Pro trial
AllSight

Sign in to AllSight

  • Follow any company — we email you the moment it files, free!
  • Your watchlist saved to your account, on every device — free!

by Signing in NOW, claim your FREE 14-day Pro trial!

No password. We email you a 6-digit code. By continuing you agree to our Terms & Privacy.
AllSight · Live plain-English 8-K decodes across the whole US market · Not investment advice.